Stocks · News reference
Ashland Launches permexa Sodium Caprate To Advance Oral Delivery Of Peptides, Biologics, And GLP‑1 Therapies
Reference Details
Connected Markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Checked
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related Headlines
Ashland to host Innovation Day for analysts and investors
Ashland Inc. will host an Innovation Day webcast on September 17, 2026, to present updates on its Technology Platforms, commercial progress, and scalability. The event will feature presentations from company executives and senior technology leaders discussing innovations and commercial opportunities across key markets. A live Q&A session will follow the formal remarks, with the webcast available for replay.
8-K/A filing — ASHLAND INC. (ASH)
Filed: 2026-08-10 AccNo: 0001193125-26-342480 Size: 145 KB Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers